Morgan Stanley Reiterates Equalweight Rating on Pfizer (PFE)

April 14, 2025 12:17 PM UTC Send to a Friend
Morgan Stanley analyst Terence Flynn reiterated an Equalweight rating and $31.00 price target on Pfizer (NYSE: PFE)The analyst comments "Following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login